First Page | Document Content | |
---|---|---|
Date: 2018-07-18 19:08:19 | PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for genoAdd to Reading ListSource URL: www.abbvie.caDownload Document from Source WebsiteFile Size: 328,56 KBShare Document on Facebook |